Salwa Saadeh

Consultant Medical Oncology/Myeloma/Leukemia/BMT

Education and Training

M.B./B.S.
MRCP (U.K.), MRCP SCE (U.K.)
Internal medicine (KAUH, Irbid, Jordan)
Medical Oncology Fellowship, King Hussein Cancer Center (KHCC), Jordan
Cancer Biology and Therapeutics Program, Harvard Medical School, USA
Advanced Hematology/BMT Fellowship, Mayo Clinic, USA

Board Certifications

Jordanian Board of Internal Medicine and Medical Oncology
MRCP (U.K.), MRCP SCE (U.K.) Medical Oncology
European Board of Hematology

Professional Memberships

American Society of Clinical Oncology (ASCO)
American Society of Hematology (ASH)
American Society of Bone and Marrow Transplantation (ASBMT)
American Association for Cancer Research (AACR)
European Hematology Association (EHA)

Awards And Honors

2018 directed research-funding donation, Mayo Clinic
2018 Above and Beyond Award, Mayo Clinic

Publications

Journal Papers:

Jambhekar N, Saadeh S, Kreuter J, Higgins A, Madde N, Jacob E, Marquez A, Hogan W, Burt J, Kor D, Warner M. Patient Blood Management Program Implementation in Hematopoietic Stem Cell Transplantation. 2018 AABB meeting, Boston, MA. October 2018
Saadeh SS, Durani U, Kansagra A, Alkhateeb H, Shah M, Ewert K, Kenderian S, Hashmi S, Patnaik M, Litzow M, Hogan W. Allogeneic hematopoietic stem cell transplant in the outpatient setting: a single center experience of 924 consecutive transplants. 2018 EHA meeting, Stockholm, Sweden. June 2018
Alkharabsheh O, Al-Kali A, Saadeh SS, He R, Viswanatha D, Greipp P, Reichard K, Shah M, Gangat N, Patnaik M, Hogan W, Litzow M, Alkhateeb H, Nguyen P. The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome per 2017 WHO guideline compared to de novo MDS. 2018 ASCO meeting, Chicago, IL. June 2018
Alkharabsheh O, Saadeh S, Patnaik M, Alkhateeb H, Gangat N, Begna K, Hogan W, Greipp P, He R, Nguyen P, Litzow M, Al-Kali A. The Impact of Clonal Size on the Revised International Prognostic Scoring System (R-IPSS) in Myelodysplastic Syndromes (MDS) with a single cytogenetic abnormality. 2018 ASCO meeting, Chicago, IL. June 2018
Saadeh SS, Alkharabsheh O, Al-Kali A, Patnaik M, Shah M, Litzow M, Hogan W, Alkhateeb H. Outcome of Patients with Myelodysplastic Syndrome and a Monosomal Karyotype Following Allogeneic Stem Cell Transplant: Single Institution Experience. 2018 BMT Tandem Meetings, Salt Lake City, Utah. Feb 2018
Saadeh SS, Alkharabsheh O, Zblewski D, Patnaik MM, Gangat N, Begna KH, Alkhateeb HB, Elliott MA, He R, Nguyen P, Hogan WJ, Litzow MR, Al-Kali A. Impact of Significant Eosinophilia in Patients with Myelodysplastic Syndromes: Single Institution Experience[abstract]. Blood, 130(Suppl 1), 5310. Retrieved from http://www.bloodjournal.org/content/130/Suppl_1/5310.
Abdel-Razeq H, Mansour A, Saadeh S, Khozouz O, Abu Nasser M. Upper extremity deep venous thrombosis among cancer patients. 5th KHCC-AUBMC-MDACC Joint conference, Beirut, Lebanon. March 2017
Madanat W, Alawneh K, Smadi M, Saadeh S, Omari M, Yazici H. The prevalence of Behcet’s disease in North Jordan. 17th International Conference on Behcet’s Disease, Matera, Italy. September 2016
Abdel-Razeq H, Marie L, Saadeh S, Abdelelah H. Four cycles of Adriamycin plus Cyclophosphamide (AC) followed by four cycles of Docetaxel (NSABP-B27) with concomitant Trastuzumab as neoadjuvant therapy for high risk early-stage, HER2-positive breast cancer patients. 4th KHCC-AUBMC-MDACC Joint Conference, Amman, Jordan. October 2015
Abdel-Razeq H, Marie L, Saadeh S, Abdelelah H, Abu-Nasser M. From clinical trials to clinical practice: Outcome of NSABP-B27 neoadjuvant chemotherapy regimen for early-stage breast cancer among Jordanian patients. 4th KHCC-AUBMC-MDACC Joint Conference, Amman, Jordan. October 2015
Abdel-Razeq H, Mansour A, Saadeh S, Makoseh M, Ismael Y, Abu Nasser M. The Application of Current Proposed Venous Thromboembolism (VTE) Risk Assessment Model (RAM) for Ambulatory Cancer Patients Would Miss Too Many. 4th KHCC-AUBMC-MDACC Joint Conference, Amman, Jordan. October 2015
Abdel-Razeq H, Mansour A, Abu-Nasser M, Saadeh S, Makoseh M, Ismael Y. Improving venous thromboembolism (VTE) prophylaxis rates among high risk admitted cancer patients [abstract]. 4th KHCC-AUBMC-MDACC Joint Conference, Amman, Jordan. October 2015
Madanat W, Alwaneh K, Smadi M, Saadeh S, Yazici H. The prevalence of Behcet’s disease in Jordan, a preliminary report. 16th International Conference on Behcet’s Disease, Paris, France. September 2014
Ayesh M, Saadeh S, Tashtoush N, Tahboub I. Disseminated intravascular coagulation induced by granulocyte colony stimulating factor in patients with acute promyelocytic leukemia [abstract]. 3rd Emirates Haematology Conference, Dubai, United Arab Emirates. March 2013.
Khassawneh B, Alawneh M, Momany S, Saadeh S. Prevalence of symptoms and risk of obstructive sleep apnea in patients with rheumatoid arthritis. 1st Sleep and Breathing Conference, Prague, Czech Republic. March 2011.

Academic Rank

Assistant Member

Contact Information

Email Address: ss.10559@khcc.jo
Phone Number: 0096265300460-1840